Eterna Therapeutics
ERNA
5 hedge funds and large institutions have $332K invested in Eterna Therapeutics in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
4% more capital invested
Capital invested by funds: $318K → $332K (+$14K)
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$152K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$30.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$167K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$26K |
| 3 |
VF
Virtu Financial
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
1
Eagle Asset Management
St Petersburg,
Florida
| $157K | +$152K | +5 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $47K | – | – | – |
|
|
NSIM
3
North Star Investment Management
Chicago,
Illinois
| $43K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $36K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $32K | +$30.4K | +1 | New |
|
6
BlackRock
New York
| $7K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $7K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
|
9
Renaissance Technologies
New York
| – | -$167K | -7 | Closed |
|
|
10
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$26K | -1 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$23K | -1 | Closed |
|
ERNA Hedge Fund Activity: Q4 2020 in Review
5 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2020, worth a combined $332K — up 4.4% from $318K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ERNA and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $152K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $167K sold.
- 5 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2020, down from 6 in Q3 2020.
- Funds reported $332K of Eterna Therapeutics stock for Q4 2020, up 4.4% quarter-over-quarter.
- 2 funds opened new Eterna Therapeutics positions in Q4 2020 and 3 closed out, a net change of -1 holder.
- The largest Eterna Therapeutics buyer in Q4 2020 was Eagle Asset Management, an estimated $152K added.
- The largest Eterna Therapeutics seller in Q4 2020 was Renaissance Technologies, an estimated $167K sold.
Based on aggregated 13F filings for Q4 2020.